BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18483249)

  • 1. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
    van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
    Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
    Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
    Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
    Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?
    Swart GW; Lunter PC; Kilsdonk JW; Kempen LC
    Cancer Metastasis Rev; 2005 Jun; 24(2):223-36. PubMed ID: 15986133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
    Jezierska A; Matysiak W; Motyl T
    Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
    Ikeda K; Quertermous T
    J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
    van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
    J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
    Hong X; Michalski CW; Kong B; Zhang W; Raggi MC; Sauliunaite D; De Oliveira T; Friess H; Kleeff J
    J Surg Oncol; 2010 Jun; 101(7):564-9. PubMed ID: 20461761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
    van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
    J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism.
    Uhlenbrock K; Eberth A; Herbrand U; Daryab N; Stege P; Meier F; Friedl P; Collard JG; Ahmadian MR
    J Cell Sci; 2004 Sep; 117(Pt 20):4863-71. PubMed ID: 15340013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALCAM/CD166: cancer-related issues.
    Weidle UH; Eggle D; Klostermann S; Swart GW
    Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.
    Darvishi B; Boroumandieh S; Majidzadeh-A K; Salehi M; Jafari F; Farahmand L
    Exp Mol Pathol; 2020 Aug; 115():104443. PubMed ID: 32380056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated leukocyte cell-adhesion molecule (ALCAM) promotes malignant phenotypes of malignant mesothelioma.
    Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Yokoi K; Osada H; Sekido Y
    J Thorac Oncol; 2012 May; 7(5):890-9. PubMed ID: 22722789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.
    Kristiansen G; Pilarsky C; Wissmann C; Stephan C; Weissbach L; Loy V; Loening S; Dietel M; Rosenthal A
    Prostate; 2003 Jan; 54(1):34-43. PubMed ID: 12481253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
    van Kempen LC; van den Oord JJ; van Muijen GN; Weidle UH; Bloemers HP; Swart GW
    Am J Pathol; 2000 Mar; 156(3):769-74. PubMed ID: 10702391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes.
    Rauch SJ; Rosenkranz AC; Böhm A; Meyer-Kirchrath J; Hohlfeld T; Schrör K; Rauch BH
    Vascul Pharmacol; 2011; 54(3-6):93-9. PubMed ID: 21440089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
    Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
    Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
    Swart GW
    Eur J Cell Biol; 2002 Jun; 81(6):313-21. PubMed ID: 12113472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALCAM (CD166) is a surface marker for early murine cardiomyocytes.
    Hirata H; Murakami Y; Miyamoto Y; Tosaka M; Inoue K; Nagahashi A; Jakt LM; Asahara T; Iwata H; Sawa Y; Kawamata S
    Cells Tissues Organs; 2006; 184(3-4):172-80. PubMed ID: 17409743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.